Giovanni Selvaggi

Giovanni Selvaggi has extensive work experience in the field of medicine and clinical consulting. giovanni is currently working as a Clinical Consultant at Tubulis GmbH since October 2023. Prior to that, they served as a Clinical Strategy Senior Advisor at Alira Health starting from September 2023. giovanni also worked as the Chief Medical Officer at ENB Therapeutics from August 2023.

From 2019 to 2022, Giovanni held multiple positions at Xcovery Holdings, Inc. including Chief Medical Officer, CEO, and CMO. giovanni served as an Executive Board Member at capracare since December 2020.

In 2022, Giovanni joined Imugene Limited as the Chief Medical Officer until July 2023. Before that, they worked at Bristol-Myers Squibb as a Program Leader Oncology and Senior Medical Director. giovanni was also the Vice President of Clinical Development at Oncolytics Biotech Inc. from 2014 to 2015. Previously, they served as the Global Clinical Leader at Novartis Oncology from 2012 to 2014.

Giovanni started their career at GlaxoSmithKline in 2010 as the Director of Clinical Development, focusing on cancer immunotherapy.

From 1986 to 1992, Giovanni Selvaggi attended the University of Torino, where they earned a Medical Doctor degree in the field of medicine.